Online Insomnia Treatment Program
Launched by KOKO HOME, INC. · Mar 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well two different online programs can help people improve their sleep. Both programs use a method called Cognitive Behavioral Therapy for Insomnia (CBT-I), which is the best-known treatment for insomnia. Participants will use either an online program or an app for six weeks, and some may receive a bedside device to help track their sleep patterns. The goal is to see if these digital tools can help people sleep better.
To join the study, participants need to be at least 18 years old and have a confirmed diagnosis of insomnia, meaning they often have trouble sleeping. They should have access to a smartphone and be able to spend about 15 minutes a day on the program. However, certain conditions like sleep apnea, restless legs syndrome, or significant mental health issues might prevent someone from participating. It's also important to note that if they receive a device, it could make sounds or lights that might wake up others in the same room.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • insomnia diagnosis or measure-confirmed moderate to severity insomnia (Insomnia Severity Index = 15-28)
- • access to an iPhone with iOS 11+ or Samsung, Google, HTC, LG, OnePlus, or Motorola phone with Android 10+
- • 18 years of age or older
- • available 15 mins per day to participate
- Exclusion Criteria:
- • Restless Legs Syndrome
- • narcolepsy
- • sleep apnea
- • sleep walking
- • bipolar disorder
- • seizures disorder
- • substance abuse
- • frailty/risk of falling
- • severe memory problems
- • shift work
- • change in antidepressant medication within past 2 months
- • serious mental/physical health problem
- • other ongoing psychological treatment w
- • sleeping with pets.
- • Participants should be aware that should they receive a device, its sound and light alerts could be disruptive to partners or others (e.g., children) that sleep in the same room.
About Koko Home, Inc.
Koko Home, Inc. is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on delivering cutting-edge solutions in the medical field, Koko Home, Inc. collaborates with healthcare professionals, researchers, and regulatory bodies to conduct rigorous clinical trials that prioritize patient safety and efficacy. The company's commitment to ethical standards and scientific excellence drives its mission to bring transformative therapies to market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Redwood City, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials